Hervé Spechbach

Validation of a commercially available SARS-CoV-2 serological immunoassay

Benjamin Meyer, Giulia Torriani, Sabine Yerly et al. · Clinical Microbiology and Infection · 2020 · 172 citations · Full text

Medicine, Immunology, Covid-19 +1

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Barco, Davide Voci, Ulrike Held et al. · The Lancet Haematology · 2022 · 55 citations · Full text

Thrombosis, Symptomatic Outpatients, Cardiovascular Disease +10

Four versus six weeks of antibiotic therapy for osteoarticular infections after implant removal: a randomized trial

Mohamed Benkabouche, Guillaume Racloz, Hervé Spechbach et al. · Journal of Antimicrobial Chemotherapy · 2019 · 54 citations · Full text

Patients’ time perception in the waiting room of an ambulatory emergency unit: a cross-sectional study

Hervé Spechbach, Jessica Rochat, Jean‐Michel Gaspoz et al. · BMC Emergency Medicine · 2019 · 52 citations · Full text

Vulnerable patients forgo health care during the first wave of the Covid-19 pandemic

Stéphanie Baggio, Nathalie Vernaz, Hervé Spechbach et al. · Preventive Medicine · 2021 · 50 citations · Full text

Covid-19 Epidemiology, Health Care Network, Pandemic Management +19